Article
Tumor neoantigens: building a framework for personalized cancer immunotherapy.
The Journal of clinical investigation - 1 Sept 2015
Gubin Matthew M, Artyomov Maxim N, Mardis Elaine R, Schreiber Robert D
Abstract excerpt
It is now well established that the immune system can recognize developing cancers and that therapeutic manipulation of immunity can induce tumor regression. The capacity to manifest remarkably durable responses in some patients has been ascribed in part to T cells that can (a) kill tumor cells directly, (b) orchestrate diverse antitumor immune responses, (c) manifest long-lasting memory, and (d) display...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
